ZURICH, Sept 19 (Reuters) – Novartis on Monday
intensified its bid to convince doctors to prescribe its heart
failure drug Entresto, releasing an analysis that concluded the
medicine contributed to…
The post UPDATE 1-Novartis intensifies Entresto push with new analysis appeared first on NASDAQ.